254 related articles for article (PubMed ID: 25389373)
1. Type I interferon signaling contributes to the bias that Toll-like receptor 4 exhibits for signaling mediated by the adaptor protein TRIF.
Kolb JP; Casella CR; SenGupta S; Chilton PM; Mitchell TC
Sci Signal; 2014 Nov; 7(351):ra108. PubMed ID: 25389373
[TBL] [Abstract][Full Text] [Related]
2. Surface immunogenic protein from Streptococcus agalactiae and
Díaz-Dinamarca DA; Salazar ML; Escobar DF; Castillo BN; Valdebenito B; Díaz P; Manubens A; Salazar F; Troncoso MF; Lavandero S; Díaz J; Becker MI; Vásquez AE
Front Immunol; 2023; 14():1186188. PubMed ID: 37790926
[TBL] [Abstract][Full Text] [Related]
3. MyD88 and TRIF synergistic interaction is required for TH1-cell polarization with a synthetic TLR4 agonist adjuvant.
Orr MT; Duthie MS; Windish HP; Lucas EA; Guderian JA; Hudson TE; Shaverdian N; O'Donnell J; Desbien AL; Reed SG; Coler RN
Eur J Immunol; 2013 Sep; 43(9):2398-408. PubMed ID: 23716300
[TBL] [Abstract][Full Text] [Related]
4. Campylobacter jejuni-induced activation of dendritic cells involves cooperative signaling through Toll-like receptor 4 (TLR4)-MyD88 and TLR4-TRIF axes.
Rathinam VA; Appledorn DM; Hoag KA; Amalfitano A; Mansfield LS
Infect Immun; 2009 Jun; 77(6):2499-507. PubMed ID: 19332531
[TBL] [Abstract][Full Text] [Related]
5. TLR4-mediated pro-inflammatory dendritic cell differentiation in humans requires the combined action of MyD88 and TRIF.
Kolanowski ST; Dieker MC; Lissenberg-Thunnissen SN; van Schijndel GM; van Ham SM; ten Brinke A
Innate Immun; 2014 May; 20(4):423-30. PubMed ID: 23941760
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of impaired NLRP3 inflammasome priming by monophosphoryl lipid A.
Embry CA; Franchi L; Nuñez G; Mitchell TC
Sci Signal; 2011 May; 4(171):ra28. PubMed ID: 21540455
[TBL] [Abstract][Full Text] [Related]
7. TRIF is required for TLR4 mediated adjuvant effects on T cell clonal expansion.
Gandhapudi SK; Chilton PM; Mitchell TC
PLoS One; 2013; 8(2):e56855. PubMed ID: 23457630
[TBL] [Abstract][Full Text] [Related]
8. Selective TRIF-dependent signaling by a synthetic toll-like receptor 4 agonist.
Bowen WS; Minns LA; Johnson DA; Mitchell TC; Hutton MM; Evans JT
Sci Signal; 2012 Feb; 5(211):ra13. PubMed ID: 22337809
[TBL] [Abstract][Full Text] [Related]
9. Recruitment of TLR adapter TRIF to TLR4 signaling complex is mediated by the second helical region of TRIF TIR domain.
Piao W; Ru LW; Piepenbrink KH; Sundberg EJ; Vogel SN; Toshchakov VY
Proc Natl Acad Sci U S A; 2013 Nov; 110(47):19036-41. PubMed ID: 24194546
[TBL] [Abstract][Full Text] [Related]
10. Role of Adaptor Protein Toll-Like Interleukin Domain Containing Adaptor Inducing Interferon β in Toll-Like Receptor 3- and 4-Mediated Regulation of Hepatic Drug Metabolizing Enzyme and Transporter Genes.
Shah P; Omoluabi O; Moorthy B; Ghose R
Drug Metab Dispos; 2016 Jan; 44(1):61-7. PubMed ID: 26470915
[TBL] [Abstract][Full Text] [Related]
11. Identification of a TLR4- and TRIF-dependent activation program of dendritic cells.
Weighardt H; Jusek G; Mages J; Lang R; Hoebe K; Beutler B; Holzmann B
Eur J Immunol; 2004 Feb; 34(2):558-64. PubMed ID: 14768061
[TBL] [Abstract][Full Text] [Related]
12. MyD88-dependent SHIP1 regulates proinflammatory signaling pathways in dendritic cells after monophosphoryl lipid A stimulation of TLR4.
Cekic C; Casella CR; Sag D; Antignano F; Kolb J; Suttles J; Hughes MR; Krystal G; Mitchell TC
J Immunol; 2011 Apr; 186(7):3858-65. PubMed ID: 21339365
[TBL] [Abstract][Full Text] [Related]
13. The toll-Like receptor adaptor TRIF contributes to otitis media pathogenesis and recovery.
Leichtle A; Hernandez M; Pak K; Webster NJ; Wasserman SI; Ryan AF
BMC Immunol; 2009 Aug; 10():45. PubMed ID: 19656404
[TBL] [Abstract][Full Text] [Related]
14. Dissociation of TRIF bias and adjuvanticity.
Richard K; Perkins DJ; Harberts EM; Song Y; Gopalakrishnan A; Shirey KA; Lai W; Vlk A; Mahurkar A; Nallar S; Hawkins LD; Ernst RK; Vogel SN
Vaccine; 2020 Jun; 38(27):4298-4308. PubMed ID: 32389496
[TBL] [Abstract][Full Text] [Related]
15. Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling.
Piao W; Song C; Chen H; Diaz MA; Wahl LM; Fitzgerald KA; Li L; Medvedev AE
J Leukoc Biol; 2009 Oct; 86(4):863-75. PubMed ID: 19656901
[TBL] [Abstract][Full Text] [Related]
16. The TIR-domain-containing adapter inducing interferon-β-dependent signaling cascade plays a crucial role in ischemia-reperfusion-induced retinal injury, whereas the contribution of the myeloid differentiation primary response 88-dependent signaling cascade is not as pivotal.
Dvoriantchikova G; Santos AR; Danek D; Dvoriantchikova X; Ivanov D
Eur J Neurosci; 2014 Aug; 40(3):2502-12. PubMed ID: 24754835
[TBL] [Abstract][Full Text] [Related]
17. The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4.
Mata-Haro V; Cekic C; Martin M; Chilton PM; Casella CR; Mitchell TC
Science; 2007 Jun; 316(5831):1628-32. PubMed ID: 17569868
[TBL] [Abstract][Full Text] [Related]
18. A role for the adaptor proteins TRAM and TRIF in toll-like receptor 2 signaling.
Nilsen NJ; Vladimer GI; Stenvik J; Orning MP; Zeid-Kilani MV; Bugge M; Bergstroem B; Conlon J; Husebye H; Hise AG; Fitzgerald KA; Espevik T; Lien E
J Biol Chem; 2015 Feb; 290(6):3209-22. PubMed ID: 25505250
[TBL] [Abstract][Full Text] [Related]
19. Regulation of lipopolysaccharide-inducible genes by MyD88 and Toll/IL-1 domain containing adaptor inducing IFN-beta.
Hirotani T; Yamamoto M; Kumagai Y; Uematsu S; Kawase I; Takeuchi O; Akira S
Biochem Biophys Res Commun; 2005 Mar; 328(2):383-92. PubMed ID: 15694359
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II-induced hypertension and cardiac hypertrophy are differentially mediated by TLR3- and TLR4-dependent pathways.
Singh MV; Cicha MZ; Nunez S; Meyerholz DK; Chapleau MW; Abboud FM
Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1027-H1038. PubMed ID: 30793936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
